FDA Inspection 1122749 — SIGDAL USA
The FDA completed an inspection of SIGDAL USA on March 10, 2020 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 10, 2020
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- New York, NY (United States)
Additional Details
FSVP